跳转至内容
Merck
CN
  • Solar photocatalytic ozonation of a mixture of pharmaceutical compounds in water.

Solar photocatalytic ozonation of a mixture of pharmaceutical compounds in water.

Chemosphere (2014-07-30)
Gracia Márquez, Eva M Rodríguez, Fernando J Beltrán, Pedro M Álvarez
摘要

Aqueous solutions of mixtures of four pharmaceutical compounds (atenolol, hydrochlorothiazide, ofloxacin and trimethoprim) both in Milli-Q ultrapure water and in a secondary effluent from a municipal wastewater treatment plant have been treated at pH 7 by different oxidation methods, such as conventional ozonation, photolytic ozonation, TiO2 catalytic ozonation, TiO2 photocatalytic oxidation and TiO2 photocatalytic ozonation. Experiments were carried out using a solar compound parabolic concentrator. The performance results have been compared in terms of removal of emerging contaminants (ECs), generation rate of phenolic intermediates, organic matter mineralization, ecotoxicity removal and enhancement of biodegradability. Also, the consumption of ozone to achieve certain treatment goals (95% removal of ECs and 40% mineralization) is discussed. Results reveal that solar photocatalytic ozonation is a promising oxidation method as it led to the best results in terms of EC mineralization (∼85%), toxicity removal (∼90%) and efficient use of ozone (∼2mgO3mgEC(-1) to achieve complete EC removal and ∼18mgO3mgTOC(-1) to achieve 40% EC mineralization, respectively).

材料
Product Number
品牌
产品描述

Sigma-Aldrich
氧化钛(IV), nanopowder, 21 nm primary particle size (TEM), ≥99.5% trace metals basis
Sigma-Aldrich
氧化钛 (IV),锐钛矿, nanopowder, <25 nm particle size, 99.7% trace metals basis
Sigma-Aldrich
甲氧苄啶, ≥98.5%
Sigma-Aldrich
氧化钛 (IV),锐钛矿, powder, 99.8% trace metals basis
Sigma-Aldrich
氧化钛(IV), ReagentPlus®, ≥99%
Sigma-Aldrich
氧化钛 (IV),锐钛矿, powder, −325 mesh, ≥99% trace metals basis
Sigma-Aldrich
钛 (IV) 氧化物,金红石型, powder, <5 μm, ≥99.9% trace metals basis
Sigma-Aldrich
氧化钛(IV), puriss., meets analytical specification of Ph. Eur., BP, USP, 99-100.5%
Sigma-Aldrich
钛 (IV) 氧化物,金红石型, nanopowder, <100 nm particle size, 99.5% trace metals basis
Sigma-Aldrich
甲氧苄啶, ≥99.0% (HPLC)
Sigma-Aldrich
氧氟沙星, fluoroquinolone antibiotic
Sigma-Aldrich
氧化钛(IV),金红石和锐钛矿混合物, nanopowder, <100 nm particle size (BET), 99.5% trace metals basis
Supelco
甲氧苄啶, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
氧化钛(IV),金红石和锐钛矿混合物, nanoparticles, <150 nm particle size (volume distribution, DLS), dispersion, 40 wt. % in H2O, 99.5% trace metals basis
Sigma-Aldrich
钛 (IV) 氧化物,金红石型, ≥99.98% trace metals basis
Supelco
氧氟沙星, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
甲氧苄啶, VETRANAL®, analytical standard
Sigma-Aldrich
钛 (IV) 氧化物,金红石型, 99.995% trace metals basis
钛, mesh, 100x100mm, nominal aperture 0.19mm, wire diameter 0.23mm, 60x60 wires/inch, open area 20%, twill weave
Sigma-Aldrich
氧化钛(IV), contains 1% Mn as dopant, nanopowder, <100 nm particle size (BET), ≥97%
Sigma-Aldrich
钛, wire, diam. 0.25 mm, 99.7% trace metals basis
Supelco
阿替洛尔标准溶液 溶液, 1.0 mg/mL in acetonitrile, ampule of 1 mL, certified reference material, Cerilliant®
USP
氧氟沙星, United States Pharmacopeia (USP) Reference Standard
USP
甲氧苄啶, United States Pharmacopeia (USP) Reference Standard
钛, mesh, 100x100mm, nominal aperture 4.3mm, wire diameter 1.5mm, 4.4x4.4 wires/inch, open area 94%, platinized diamond mesh
Supelco
氢氯噻嗪 溶液, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®
Supelco
氧氟沙星, VETRANAL®, analytical standard
Sigma-Aldrich
钛 (IV) 氧化物,金红石型, <001>, (single crystal substrate), ≥99.9% trace metals basis, L × W × thickness 10 mm × 10 mm × 0.5 mm
Sigma-Aldrich
钛, foil, thickness 2.0 mm, 99.7% trace metals basis
Sigma-Aldrich
氢氯噻嗪, meets USP testing specifications